Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

CNS Therapies Contribute Rising Share Of Breakthrough Designations

Feb 29 2016

Related Content

Ocrelizumab May Represent Roche’s Rebound In Neuroscience

Jun 30 2015

BioMarin's Drisapersen 'Compete Response' Shows FDA Flexibility Still Limited

Jan 14 2016

Related Companies

Genentech, Inc.

Trevena Inc.

BioMarin Pharmaceutical Inc.

Acadia Pharmaceuticals Inc.

Neurocrine Biosciences, Inc.

Teva Pharmaceutical Industries Ltd.

Johnson & Johnson

Allergan plc

Additional Topics

Clinical Trials Regulation BioPharmaceutical

More from Clinical Trials

More from R&D

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window